TRAX First Tracks Biotherapeutics, Inc.
Price Chart
Executive Summary
First Tracks Biotherapeutics' S-1 registration (333-295719) became effective on May 12, 2026, covering the resale of up to 10,497,054 shares by selling stockholders. The company receives no proceeds from this offering, which stems from a March 2026 private placement that raised ~$80M at $13.81/share. The effectiveness creates a near-term overhang as the registered shares become freely tradable, though the company itself is not raising capital.
Actionable Insight
The effectiveness unlocks a large block of shares for secondary selling, creating near-term overhang. Monitor for any selling stockholder filings (Form 144) or volume spikes in the coming days. The company's cash position was recently boosted by the $80M private placement, so no immediate capital need — but the overhang may cap upside until the registered shares are absorbed.
Key Facts
- S-1 registration effective May 12, 2026 (SEC File No. 333-295719)
- Covers resale of up to 10,497,054 shares by selling stockholders
- Company receives no proceeds from this offering
- Shares stem from March 2026 private placement at $13.81/share raising ~$80M for the company
- Effectiveness date: May 12, 2026; filing accepted May 13, 2026
Financial Impact
Up to 10.5M shares become eligible for resale, representing ~16.9% of current shares outstanding (based on ~62M shares at $621M market cap / ~$10 stock price). No new capital raised by the company.
Risk Factors
- Near-term selling pressure from registered shares entering the market
- Potential price suppression until the overhang clears
- No company proceeds from this offering — dilution without capital benefit
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001596 |
| Document: 9999999995-26-001596-index.html | 9999999995-26-001596 |
| Document: 9999999995-26-001596.txt | 9999999995-26-001596 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 14, 2026
29d ago
|
8-K
| $16.90 $17.18 | ▲ +1.66% | ▲ +0.69% | $17.64 (+4.38%) |
|
May 13, 2026
4w ago
|
EFFECT
| $18.43 $16.66 | ▼ −9.60% | ▼ −8.45% | $17.64 (−4.29%) |
|
May 8, 2026
5w ago
|
S-1
| $18.76 $17.79 | ▼ −5.17% | ▼ −5.09% | $17.64 (−5.97%) |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
|
Apr 1, 2026
10w ago
|
3
| — | awaiting T+5 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access